Weight Gain After Fecal Microbiota Transplantation

Fecal microbiota transplantation (FMT) is a promising treatment for recurrent Clostridium difficile infection. We report a case of a woman successfully treated with FMT who developed new-onset obesity after receiving stool from a healthy but overweight donor. This case may stimulate further studies on the mechanisms of the nutritional-neural-microbiota axis and reports of outcomes in patients who have used nonideal donors for FMT.

• Publication year

  2015

• Venue

  Open Forum Infectious Diseases

• Publication date

  2015-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ofid/ofv004PMID 26034755PMCID 4438885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study.

  2014influential reference
• Review article: associations between Helicobacter pylori and obesity ‐ an ecological study

  2014cited by this paper
• Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice

  2013cited by this paper

• Antibiotic-Mediated Modulation of the Gut Microbiome Identifies Taurine as a Modulator of Adipocyte Function Through TGR5 Signaling

  2026cites this paper
• Intestinal Microbiota Modulation by Fecal Microbiota Transplantation in Nonalcoholic Fatty Liver Disease

  2025cites this paper
• Impact of fecal microbiota transplantation in dogs

  2025cites this paper
• Fecal Microbiota Transplantation in Alzheimer’s Disease: Mechanistic Insights Through the Microbiota–Gut–Brain Axis and Therapeutic Prospects

  2025cites this paper
• A designed synthetic microbiota provides insight to community function in Clostridioides difficile resistance.

  2025cites this paper
• Implication of Gut Mycobiome and Virome in Type-2 Diabetes Mellitus: Uncovering the Hidden Players

  2025cites this paper
• Gerobiotics: Exploring the Potential and Limitations of Repurposing Probiotics in Addressing Aging Hallmarks and Chronic Diseases.

  2025cites this paper
• The Gut Microbiome Obesity Index: A New Analytical Tool in the Metagenomics Workflow for the Evaluation of Gut Dysbiosis in Obese Humans

  2025cites this paper
• Fecal microbiome transplantation in the treatment of chronic enteropathies.

  2025cites this paper
• Body mass index changes after fecal microbiota transplantation for recurrent Clostridioides difficile infection

  2025cites this paper
• Microbiome mismatches from microbiota transplants lead to persistent off-target metabolic and immunomodulatory effects.

  2025cites this paper
• Microecological regulation in HCC therapy: Gut microbiome enhances ICI treatment.

  2024cites this paper
• Deciphering the complex interplay of risk factors in type 2 diabetes mellitus: A comprehensive review

  2024cites this paper
• Place du transfert du microbiote fécal

  2024cites this paper
• Human Gut Microbiota in Cardiovascular Disease.

  2024cites this paper
• Personalised medicine based on host genetics and microbiota applied to colorectal cancer.

  2024cites this paper
• The role of fecal microbiota transplantation in type 2 diabetes mellitus treatment

  2024cites this paper
• European Practice for CDI Treatment.

  2024cites this paper
• Pediatric Obesity and Non-Hepatobiliary Gastrointestinal Disorders: A Comprehensive Review

  2024cites this paper
• Host origin of microbiota drives functional recovery and Clostridioides difficile clearance in mice

  2024cites this paper
• The complex link between the gut microbiome and obesity-associated metabolic disorders: Mechanisms and therapeutic opportunities

  2024cites this paper
• Gut Microbiota Disorders and Metabolic Syndrome: Tales of a Crosstalk Process.

  2024cites this paper
• Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice.

  2023cites this paper
• Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).

  2023cites this paper
• A Taxonomy-Agnostic Approach to Targeted Microbiome Therapeutics—Leveraging Principles of Systems Biology

  2023cites this paper
• Overview of current detection methods and microRNA potential in Clostridioides difficile infection screening

  2023cites this paper
• Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence.

  2023cites this paper
• Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application.

  2023cites this paper
• The Intestinal Microbiome and the Metabolic Syndrome—How Its Manipulation May Affect Metabolic-Associated Fatty Liver Disease (MAFLD)

  2023cites this paper
• Research Progress of Fecal Microbiota Transplantation in Liver Diseases

  2023cites this paper
• The role of gut fungi in Clostridioides difficile infection

  2023cites this paper
• Gut microbiota in relationship to diabetes mellitus and its late complications with a focus on diabetic foot syndrome: A review

  2023cites this paper
• Is Autologous Fecal Microbiota Transfer after Exclusive Enteral Nutrition in Pediatric Crohn’s Disease Patients Rational and Feasible? Data from a Feasibility Test

  2023cites this paper
• Liver-Gut-Interaction: Role of Microbiome Transplantation in the Future Treatment of Metabolic Disease

  2023cites this paper
• Fecal transplantation for treatment of inflammatory bowel disease.

  2023cites this paper
• Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities

  2023cites this paper
• Controlling the human microbiome.

  2023cites this paper
• Influence of the Mediterranean Diet on Healthy Aging

  2023cites this paper
• Human gut microbiome: Therapeutic opportunities for metabolic syndrome—Hype or hope?

  2023cites this paper
• Evaluating Gut Microbiota Modification as a Next-Generation Therapy for Obesity and Diabetes.

  2023cites this paper
• Associations between the gut microbiome and metabolic, inflammatory, and appetitive effects of sleeve gastrectomy

  2023influential citation
• Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors

  2023cites this paper
• Mediterranean diet and olive oil, microbiota, and obesity-related cancers. From mechanisms to prevention.

  2023cites this paper
• Gut microbiota: A new target for T2DM prevention and treatment

  2022cites this paper
• Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment

  2022cites this paper
• Adverse events of intestinal microbiota transplantation in randomized controlled trials: a systematic review and meta-analysis

  2022cites this paper
• Role of the microbiome in oral cancer occurrence, progression and therapy.

  2022cites this paper
• Gut microbiota in bariatric surgery

  2022cites this paper
• USO DE PROBIÓTICOS NO TRATAMENTO DA OBESIDADE: PERSPECTIVAS

  2022cites this paper
• Fecal microbiota transplantation treatment for type 1 diabetes mellitus with malnutrition: a case report

  2022cites this paper
• Host—microbial interactions in metabolic diseases: from diet to immunity

  2022cites this paper
• Implications of microbe-mediated crosstalk in the gut: Impact on metabolic diseases.

  2022cites this paper
• Microbiota, Microbiome, and Retinal Diseases

  2022cites this paper
• The Age of Next-Generation Therapeutic-Microbe Discovery: Exploiting Microbe-Microbe and Host-Microbe Interactions for Disease Prevention

  2022cites this paper
• Model-guided design of the diversity of a synthetic human gut community

  2022cites this paper
• Personal diet-microbiota interactions and weight loss.

  2022cites this paper
• Does the gut microbiome mediate antipsychotic-induced metabolic side effects in schizophrenia?

  2022cites this paper
• Fecal Microbiota Transplant for Hematologic and Oncologic Diseases: Principle and Practice

  2022cites this paper
• Conference on ‘ Obesity and the brain ’ Symposium four: Personalised medicine for obesity prevention and management Personal diet – microbiota interactions and weight loss

  2022cites this paper
• Whole-Genome Shotgun Metagenomic Sequencing Reveals Distinct Gut Microbiome Signatures of Obese Cats

  2022cites this paper
• Recent Advances in Understanding the Structure and Function of the Human Microbiome

  2022cites this paper
• Fecal microbiota transplantation across the lifespan: balancing efficacy, safety, and innovation.

  2022cites this paper
• [Fecal Microbiota Transfer (FMT) in Children and Adolescents - Review and statement by the GPGE microbiome working group].

  2022cites this paper
• From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii

  2022cites this paper
• MAFLD under the lens: the role of gut microbiota

  2022cites this paper
• Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies

  2022cites this paper
• Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols

  2022cites this paper
• Extremely small and incredibly close: Gut microbes as modulators of inflammation and targets for therapeutic intervention

  2022cites this paper
• The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer

  2022cites this paper
• Healthy Microbiome - A Mere Idea Or A Sound Concept? (Review).

  2022cites this paper
• The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease

  2022cites this paper
• The global incidence of adverse events associated with fecal microbiota transplantation in children over the past 20 years: A systematic review and meta‐analysis

  2022cites this paper
• The Role of the Gut Microbiome in Pediatric Obesity and Bariatric Surgery

  2022cites this paper
• Orchestrating the fecal microbiota transplantation: Current technological advancements and potential biomedical application

  2022cites this paper
• Safety of fecal microbiota transplantation for Clostridioides difficile infection focusing on pathobionts and SARS-CoV-2

  2021cites this paper
• Host-microbial interactions in the metabolism of different dietary fats.

  2021cites this paper
• Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites

  2021cites this paper
• Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study

  2021cites this paper
• The link among microbiota, epigenetics, and disease development

  2021cites this paper
• Microbiota intestinal y obesidad

  2021cites this paper
• Fecal Microbiota Transplantation: The Evolving Risk Landscape.

  2021cites this paper
• Fecal Microbiota Transplantation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review

  2021cites this paper
• Eating microRNAs: pharmacological opportunities for cross‐kingdom regulation and implications in host gene and gut microbiota modulation

  2021cites this paper
• Romanian National Guideline on Translating Fecal Microbiota Transplantation Applications related to Clostridioides difficile Infections into the Local Clinical Practice.

  2021cites this paper
• Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.

  2021cites this paper
• Targeting the Gut Microbiota for Remediating Obesity and Related Metabolic Disorders.

  2021cites this paper
• The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD.

  2021cites this paper
• Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic

  2021cites this paper
• Current and future applications of fecal microbiota transplantation for children

  2021cites this paper
• Obesity; Its Prevalence, Consequences and Potential Therapies

  2021cites this paper
• Next-generation prebiotic promotes selective growth of bifidobacteria, suppressing Clostridioides difficile

  2021cites this paper
• Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy

  2021cites this paper
• Adverse events of fecal microbiota transplantation: a meta-analysis of high-quality studies

  2021cites this paper
• De novo lipogenesis in non‐alcoholic fatty liver disease: Quantification with stable isotope tracers

  2021cites this paper
• The Gut-Microbiota-Brain Axis in Autism Spectrum Disorder

  2021cites this paper
• Microbiota and epigenetics: promising therapeutic approaches?

  2021cites this paper
• Oral angiotensin-(1-7) peptide modulates intestinal microbiota improving metabolic profile in obese mice.

  2021cites this paper
• Systemic Antibiotics and Obesity: Analyses from a Population-Based Cohort

  2021cites this paper
• Recent Progress in Metabolic Syndrome Research and Therapeutics

  2021cites this paper
• The gut microbiome and efficacy of cancer immunotherapy.

  2021cites this paper